The Directory of Open Access Journals
DOAJ Logotype
Open
Global
Trusted
Main actions
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Search
Menu
Secondary actions
Search
Journals
Articles
Documentation
API
OAI-PMH
Widgets
Public data dump
OpenURL
XML
Metadata help
Preservation
About
About DOAJ
DOAJ at 20
DOAJ team
Ambassadors
Advisory Board & Council
Volunteers
News
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Login
Login
Quick search
Close
×
Journals
Articles
Search by keywords:
In the field:
In all fields
Title
ISSN
Subject
Publisher
Country of publisher
Search
Frontiers in Oncology
(Apr 2021)
Corrigendum: Salivary Gland Carcinoma: Novel Targets to Overcome Treatment Resistance in Advanced Disease
Larissa Di Villeneuve,
Ive Lima Souza,
Fernanda Davila Sampaio Tolentino,
Renata Ferrarotto,
Gustavo Schvartsman
Affiliations
Larissa Di Villeneuve
Department of Medical Oncology, Hospital Israelita Albert Einstein, São Paulo, Brazil
Ive Lima Souza
Department of Medical Oncology, Hospital Israelita Albert Einstein, São Paulo, Brazil
Fernanda Davila Sampaio Tolentino
Department of Medical Oncology, Hospital Israelita Albert Einstein, São Paulo, Brazil
Renata Ferrarotto
Department of Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States
Gustavo Schvartsman
Department of Medical Oncology, Hospital Israelita Albert Einstein, São Paulo, Brazil
DOI
https://doi.org/10.3389/fonc.2021.669486
Journal volume & issue
Vol. 11
Abstract
Read online
No abstracts available.
Keywords
salivary gland cancer
molecular targeted therapy
androgen receptor
immunotherapy
ERBB-2 receptor
gene fusion
WeChat QR code
Close